Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol.
Hummel S, Käßl A, Arnolds S, Achenbach P, Berner R, Casteels K, Hyöty H, Kordonouri O, Larsson HE, Lundgren M, Marcovecchio ML, Owen C, Pfirrmann M, Robson S, Szadkowska A, Szypowska A, Tree T, Weiss A, Ziegler AG, Bonifacio E; GPPAD Study Group.
Hummel S, et al.
Contemp Clin Trials Commun. 2025 Jan 20;44:101434. doi: 10.1016/j.conctc.2025.101434. eCollection 2025 Apr.
Contemp Clin Trials Commun. 2025.
PMID: 39916680
Free PMC article.